Manmeet S. Soni

Manmeet S. Soni

Mr. Soni has served as Chief Financial Officer and Executive Vice President of Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in the regulation of cellular metabolism and inflammation, since August 2019.  Continue reading

Garry A. Neil, MD

Dr. Neil has served on our Board of Directors since February 2017.  Dr. Neil serves as the Chief Scientific Officer of Aevi Genomic Medicine, a publicly held biotechnology company focused on translating genetic discoveries into novel therapies to improve Continue reading

Kieran T. Gallahue

Mr. Gallahue has served as a member of our Board of Directors since July 2018.   Mr. Gallahue served as Chairman and Chief Executive Officer of CareFusion Corporation, a medical products company, from 2011 until its acquisition by Becton, Dickinson and Company in 2015 for $12.3 billion. Continue reading

Oliver Fetzer, PhD

Dr. Fetzer has served on our Board of Directors since February 2017.  Dr. Fetzer has served as the Chief Executive Officer of Synthetic Genomics, Inc., a private synthetic biology company commercializing genomic technologies, since November 2014. Continue reading

Jayson Dallas, MD

Dr. Dallas has served on our Board of Directors since February 2017.  Dr. Dallas has served as President and Chief Executive Officer of Aimmune Therapeutics, Inc., a biopharmaceutical company developing treatments for potentially life-threatening food allergies, since June 2018. Continue reading